Beyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
On 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target
On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target
How do you explain such a big difference in valuation?
Where do you see this Bull Pennant heading?
On 8/13/2021 Chardan Capital brokerage Lowered the Price Target for the Buy rating from $55.00 to $22.00
On 8/10/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $19.00
My price target is the strong 14.5usd resistance.
Short Float 12.76%
52 Week Range 6.68 - 53.75
Now the price is 8.95usd
Been in this for a little while now since the change in market structure and added a few times to this position so not the best avg weighted entry but still well in profit.
Classic sweep of lows and change in market structure has me excited on this position and more recently over the last month with the gap up above the previous short term high and now the...
#MSOgang small caps. Investing ain't easy. Rule # whatever, don't be cute. Vaccine play is overplayed.
2021 is not a repeat of '20. A rising rate environment is in works. $GNLN #thegem #cannabisreform
Diamyd chart has repeated this descending wedge pattern, followed by breakouts, thrice during the past three months. A fourth inning is in sight, as they are getting ready to head into the phase III clinical trials (labeled "DIAGNODE-3") of their diabetes vaccine "Diamyd".
NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily.
Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug.
High risk with potentially high reward: up to a 25% drawdown and a...
Supposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast..
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect...
SIOX forming up support in the $1.50-$2 range and building up nicely for a breakout, with earnings coming up on August 17th it could be all the catalyst we need for it to spike to the $3 range by early September..
only buy if the candle doesn't cross and close 518 downwards. and buy on the end of day when the candle closes green or a couple of long wicks downwards on day candle. 60-70 percent return expected in 1 and half to 2 months. and 250/300 percent expected in a year and half to 2 years for long hold.
I am long ISEE. I see this stock is about to POP (but watching closely in case it is a bust).
I am long ISEE because
We broke $9, previous resistance
There are no other resistance areas until last sell off in 2017
MACD cross over bullish
RSI bullish with HH
Break out of BBand after narrow band
Pharma is all the rage :D
Our target prices are...
Celsion is at a key support level & may bounce at this point. Potential move to 600 ema?
Seeing multiple confluences.
Volume is extremely low.
Keeping an eye on this one. Lot's in the works.